These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 17420277)

  • 1. Wilms' tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2.
    Klattig J; Sierig R; Kruspe D; Besenbeck B; Englert C
    Mol Cell Biol; 2007 Jun; 27(12):4355-64. PubMed ID: 17420277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification, expression, and regulation of anti-Müllerian hormone type-II receptor in the embryonic chicken gonad.
    Cutting AD; Ayers K; Davidson N; Oshlack A; Doran T; Sinclair AH; Tizard M; Smith CA
    Biol Reprod; 2014 May; 90(5):106. PubMed ID: 24621923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
    Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
    Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Wilms tumor 1 (WT1) in the transcriptional regulation of the Mullerian-inhibiting substance promoter.
    Hossain A; Saunders GF
    Biol Reprod; 2003 Dec; 69(6):1808-14. PubMed ID: 12855602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter.
    Lee TH; Pelletier J
    Physiol Genomics; 2001 Dec; 7(2):187-200. PubMed ID: 11773605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
    Morrison AA; Viney RL; Saleem MA; Ladomery MR
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1.
    Wilhelm D; Englert C
    Genes Dev; 2002 Jul; 16(14):1839-51. PubMed ID: 12130543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells.
    Kirschner KM; Hagen P; Hussels CS; Ballmaier M; Scholz H; Dame C
    FASEB J; 2008 Aug; 22(8):2690-701. PubMed ID: 18424770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
    Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
    Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak.
    Morrison DJ; English MA; Licht JD
    Cancer Res; 2005 Sep; 65(18):8174-82. PubMed ID: 16166292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport.
    Belville C; Maréchal JD; Pennetier S; Carmillo P; Masgrau L; Messika-Zeitoun L; Galey J; Machado G; Treton D; Gonzalès J; Picard JY; Josso N; Cate RL; di Clemente N
    Hum Mol Genet; 2009 Aug; 18(16):3002-13. PubMed ID: 19457927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT1-mediated gene regulation in early urogenital ridge development.
    Klattig J; Sierig R; Kruspe D; Makki MS; Englert C
    Sex Dev; 2007; 1(4):238-54. PubMed ID: 18391535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A GATA4/WT1 cooperation regulates transcription of genes required for mammalian sex determination and differentiation.
    Miyamoto Y; Taniguchi H; Hamel F; Silversides DW; Viger RS
    BMC Mol Biol; 2008 Apr; 9():44. PubMed ID: 18445271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor.
    Barbosa AS; Hadjiathanasiou CG; Theodoridis C; Papathanasiou A; Tar A; Merksz M; Györvári B; Sultan C; Dumas R; Jaubert F; Niaudet P; Moreira-Filho CA; Cotinot C; Fellous M
    Hum Mutat; 1999; 13(2):146-53. PubMed ID: 10094551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
    Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.